Advanced Pharmacometric Simulation & Modeling Masterclass is a comprehensive two half-day virtual masterclass designed to foster effective interdisciplinary collaboration between pharmacometricians and scientists involved in non-clinical or clinical drug development.
Whether you're involved in preclinical studies to guide biopharmaceutical development, characterize the pharmacokinetic profile of innovative formulations, optimize in vivo treatment schedules, or conduct clinical research to refine drug delivery, minimize toxicity, and personalize dosing regimens, this course is designed to support your drug development decision-making process.
Through a blend of theoretical frameworks and hands-on workshops, you'll develop practical skills in using specialized pharmacometric software tools, preparing and analyzing PK data, and applying model-based approaches to optimize therapeutic strategies. By bridging the gap between pharmacometricians and researchers, the course promotes effective communication and collaborative decision-making, ultimately leading to more efficient and model-based therapeutic development.
By the end of this intensive masterclass, you will be able to:
Bridge theory and application in drug development - Connect fundamental pharmacokinetic principles with practical applications in optimizing therapeutic regimens
Master specialized pharmacometric software tools - Gain hands-on experience with industry-standard platforms through guided workshops
Enhance data preparation and management skills - Learn efficient techniques for organizing and structuring PK data for robust analysis
Develop model-based decision-making abilities - Apply population pharmacokinetic modeling to inform critical drug development decisions
Design personalized dosing strategies - Explore methods to account for patient variability and optimize individual treatment approaches
Improve interdisciplinary communication - Develop a common language to facilitate collaboration between pharmacometricians and other scientific disciplines
Professor Joseph Ciccolini is Full Professor of Pharmacokinetics at the Faculty of Pharmacy, University of Aix-Marseille, Clinical Pharmacologist at the University Hospital of Marseille, and Group Leader of the COMPO Research Team (Inserm Inria) at the Cancer Research Centre of Marseille.
Prof. Ciccolini is currently Chair of the PAMM-EORTC group dedicated to the promotion of pharmacokinetics, pharmacometrics, and pharmacogenetics in oncology. His research focuses on the control of pharmacokinetic variability in oncology and the development of adaptive dosing strategies at the bedside. At the bench, Prof. Ciccolini's work focuses on improving the PK characteristics of anticancer drugs through the development of nanoparticles.
Dr. Anne Rodallec is an Assistant Professor at the Faculty of Pharmacy, Aix-Marseille University, where she teaches the fundamentals of pharmacokinetics and gives workshops on PK modeling to future pharmacists, medical doctors, and health professionals. She obtained her PharmD and PhD in Pharmacokinetics and Oncology at the same university.
She is a tenured researcher at the COMPO research team (Inserm Inria) at the Cancer Research Center of Marseille. Her research background focuses on the development of liposomal drug delivery systems in oncology, encompassing formulation, in vivo evaluation, and pharmacokinetic modeling. Currently, she is investigating the combination of these nanocarriers with immunotherapies to optimize treatment regimens through advanced pharmacokinetic models.
Dr. Rodallec is actively involved in the Controlled Release Society (CRS), where she co-organizes events and facilitates interdisciplinary collaboration among researchers. Her collaborative efforts extend to assisting chemists in developing innovative drugs and determining optimal administration strategies in preclinical settings using model-informed techniques. Recently, she served as a guest researcher at the University of Bonn's Pharmaceutical Development department.